Pfizer’s chief executive has revealed that two doses of its current Covid-19 vaccine offer “very limited protection, if any” against the Omicron variant.Albert Bourla made the comments in an interview with Yahoo Finance after the company announced a new Omicron-specific version of the vaccine would be ready by March, with doses already being manufactured.“We know that the two doses of the vaccine offer very limited protection, if any,” Dr Bourla said.
https://www.euro.who.int/en/health-topics/health-emergencies/pages/news/news/2022/01/the-omicron-variant-sorting-fact-from-myth
